All Type of News
KFDA mulls introduction of vendor audit system for raw materials
The government plans to introduce the vendor audit (supplier audit) system as pharmaceutical raw materials should be validated under the current GMP system from next year, the Korea Food and Drug Administration said r...
Drug makers, wholesalers urged to promote more concerted efforts
In the current environment of pricing pressure, it is essential for pharmaceutical firms and wholesaler to strengthen their mutual cooperation, market analysts say.
As things stand, the high profitability of pharma...
Daewoong, Wyeth are at odds over new drug agreement
Daewoong Pharm said on November 30 the company plans to appeal the International Arbitration Court over the dispute arising from the Wyeth Pharmaceutical’s unilateral cancellation of the contract between a biopharmace...
Green Cross names new executives in shake-up
Green Cross Corporation (GCC), the local leading pharmaceutical maker, said on November 30 that it promoted Huh Il-sub, incumbent vice chairman, as its chairman
The country’s leading vaccine maker also appointed t...
Health insurance allowance re-possible for oral ginkgo biloba extracts
The Ministry of Health, Welfare and Family Affairs announced on November 20 that SK Chemicals’ Ginexin and Yuyu’s Tanamin (EGb 761) are re-eligible for health insurance from December 1, as long as the two drugs may be...
Korea’s medicine price to be studied
The government plans to compare the prices of 73 medicines in 15 countries, including the United States, Japan, U.K., France and Switzerland, with those of Korea, according to the National Health Insurance Corporation...
Korean drugmakers to suffer damage of 2 trillion won
The Korea Pharmaceutical Manufacturers Association claims that the domestic market will suffer damage of 2 trillion won due to the government’s relentless drug price-cut policy.
The sum is equivalent to at least 1...
Per capita medication expense averages 210,000 won last year
A Korean spent an annual average of 210,000 won on medicine expense in 2008, according to a report released by the National Health Insurance Corporation and the Health Insurance Review and Assessment Service.
This ...
Hospital pharmacist group’s plan faces mounting criticism
The hospital pharmacist association’s employment plan faced bitter criticism from the Korean Hospital Association.
KHA officials raised doubts over the plan that each hospital should employee a pharmacist per 30 be...
Hanmi, Lundbeck Korea to reinforce local co-marketing of Ebixa for treatment of moderate to severe A
Hanmi Pharm said on November 27 that it has signed an agreement with Lundbeck Korea with an aim to co-promote Ebixa (memantine 10mg), anti-dementia agent, in Korea for the next five years.
A November 26 signing cer...
